Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Why MNKD may be a lousy investment even if Afrezza is a great drug/device

Simple fact is that Al can dilute the rest of the share holders without diluting himself. Al will get half of the return no matter what the ultimate share count will be. It can reach 300 million, 500 million, or a billion. Al will always hold half of it. Can we afford and have the opportunity to keep buying in at the diluted price for each secondary? I guess not.

Share
New Message
Please login to post a reply